EDIT - Editas Medicine Inc
IEX Last Trade
3.75
0.040 1.067%
Share volume: 1,135,914
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.71
0.04
1.08%
Summary score
12%
Profitability
0%
Dept financing
8%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.48%
Return on assets
-8.17%
Return on sales
-10360.38%
Return on invested capital
-52.11%
Total debt ratio
25.3%
Debt ratio change over timeo
-1.45%
Current Ratio
8.73%
Quick Ratio
8.73%
Cash Position Ratio
7.93%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.25%
Return on assets
-9.52%
Return on sales
-2102.4%
Return on invested capital
-62.19%
Total debt ratio
29.5%
Debt ratio change over timeo
-1.71%
Current Ratio
6.05%
Quick Ratio
6.05%
Cash Position Ratio
5.86%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-21.04%
Return on assets
-15.21%
Return on sales
-5902.29%
Return on invested capital
-90.7%
Total debt ratio
33.14%
Debt ratio change over time
-2.67%
Current Ratio
4.6%
Quick Ratio
4.6%
Cash Position Ratio
4.45%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-79.88%
Return on assets
-84.5%
Return on sales
13330.27%
Return on invested capital
-2.37%
Total debt ratio
-144.76%
Debt ratio change over time
-1.45%
Current Ratio
-16%
Quick Ratio
-16%
Cash Position Ratio
-14.8%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EDIT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.48% | 13.79% | 34.47% | 7.43% |
| Return on assets | -8.17% | 2.76% | 3.15% | 5.62% |
| Return on sales | -10360.38% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -52.11% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 25.3% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.45% | 308.97% | -6.99% | 1.18% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 6.05% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.05% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.86% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 13% | 30% |
| Short-term ratios | EDIT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.25% | 13.77% | 13.25% | 3.8% |
| Return on assets | -9.52% | 2.43% | 1.89% | 3.09% |
| Return on sales | -2102.4% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -62.19% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 29.5% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.71% | 46.38% | -72.08% | 1.51% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 6.05% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.05% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.86% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 9% | 22% | 54% |